Efficacy of Statewide Neonatal Screening for Cystic Fibrosis by Assay of Trypsinogen Concentrations
Open Access
- 12 September 1991
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 325 (11) , 769-774
- https://doi.org/10.1056/nejm199109123251104
Abstract
To evaluate the feasibility and efficacy of measuring immunoreactive trypsinogen in blood to screen for cystic fibrosis, we performed this test in 279,399 newborns in Colorado from 1982 to 1987.Keywords
This publication has 20 references indexed in Scilit:
- Pancreatic Function in Infants Identified as Having Cystic Fibrosis in a Neonatal Screening ProgramNew England Journal of Medicine, 1990
- Identification of the Cystic Fibrosis Gene: Chromosome Walking and JumpingScience, 1989
- Total Body Potassium in Cystic FibrosisJournal of Pediatric Gastroenterology and Nutrition, 1989
- Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screeningThe Journal of Pediatrics, 1989
- Immunoreactive trypsinogen screening for cystic fibrosis: Characterization of infants with a false‐positive screening testPediatric Pulmonology, 1989
- Nutritional deficits exist before 2 months of age in some infants with cystic fibrosis identified by screening testThe Journal of Pediatrics, 1984
- IMMUNOREACTIVE PANCREATIC LIPASE TEST FOR NEONATAL DETECTION OF CYSTIC FIBROSISThe Lancet, 1984
- Cystic fibrosis screening by dried blood spot trypsin assay: Results in 75,000 newborn infantsThe Journal of Pediatrics, 1983
- TWO TIER SCREEN FOR CYSTIC FIBROSISThe Lancet, 1981
- The Decline of the Sweat TestClinical Pediatrics, 1973